Cargando…
Repositioning small molecule drugs as allosteric inhibitors of the BFT‐3 toxin from enterotoxigenic Bacteroides fragilis
Bacteroides fragilis is an abundant commensal component of the healthy human colon. However, under dysbiotic conditions, enterotoxigenic B. fragilis (ETBF) may arise and elicit diarrhea, anaerobic bacteremia, inflammatory bowel disease, and colorectal cancer. Most worrisome, ETBF is resistant to man...
Autores principales: | Jimenez‐Alesanco, Ana, Eckhard, Ulrich, Asencio del Rio, Marta, Vega, Sonia, Guevara, Tibisay, Velazquez‐Campoy, Adrian, Gomis‐Rüth, Francesc Xavier, Abian, Olga |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9514063/ https://www.ncbi.nlm.nih.gov/pubmed/36173175 http://dx.doi.org/10.1002/pro.4427 |
Ejemplares similares
-
Monoclonal antibodies specific for Bacteroides fragilis enterotoxins BFT1 and BFT2 and their use in immunoassays
por: Mootien, Saraspadee, et al.
Publicado: (2017) -
Genomic Diversity of Enterotoxigenic Strains of Bacteroides fragilis
por: Pierce, Jessica V., et al.
Publicado: (2016) -
Enterotoxigenic and non-enterotoxigenic Bacteroides
fragilis from fecal microbiota of children
por: Ignacio, Aline, et al.
Publicado: (2015) -
Detection of enterotoxigenic Bacteroides fragilis in patients with ulcerative colitis
por: Zamani, Samin, et al.
Publicado: (2017) -
Isolation, Detection, and Characterization of Enterotoxigenic Bacteroides fragilis in Clinical Samples
por: Fathi, Payam, et al.
Publicado: (2016)